Lifeward Ltd. (LFWD)
0.7075
-0.05
(-6.81%)
USD |
NASDAQ |
Dec 11, 16:00
0.7154
+0.01
(+1.12%)
Pre-Market: 08:36
Lifeward Research and Development Expense (Quarterly): 0.721M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 17.10M |
| Twist Bioscience Corp. | 17.01M |
| Perspective Therapeutics, Inc. | 19.56M |
| Xtant Medical Holdings, Inc. | 0.634M |
| VolitionRX Ltd. | 2.022M |